ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer

ClinicalTrials.gov ID: NCT06910761

Public ClinicalTrials.gov record NCT06910761. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 8:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Trial of Photon Craniospinal Irradiation for Leptomeningeal Disease Secondary to Solid Tumor Malignancy

Study identification

NCT ID
NCT06910761
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
City of Hope Medical Center
Other
Enrollment
35 participants

Conditions and interventions

Interventions

  • Biospecimen Collection Procedure
  • Craniospinal Irradiation Radiation
  • Electronic Health Record Review Other
  • Lumbar Puncture Procedure
  • Magnetic Resonance Imaging Procedure
  • Ommaya Reservoir Tap Procedure
  • Questionnaire Administration Other
  • Volume Modulated Arc Therapy Radiation

Procedure · Radiation · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 4, 2025
Primary completion
Oct 1, 2028
Completion
Oct 1, 2028
Last update posted
Dec 7, 2025

2025 – 2028

United States locations

U.S. sites
2
U.S. states
1
U.S. cities
2
Facility City State ZIP Site status
City of Hope Medical Center Duarte California 91010 Recruiting
City of Hope at Irvine Lennar Irvine California 92618 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06910761, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 7, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06910761 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →